Cambridge, MA, United States of America

Eric Stefan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Dana-Farber-Cancer Institute Inc., The Broad Institute, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Stefan. Retrieved from https://idiyas.com/inventor/eric-stefan-vh01xsy0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eric Stefan: Innovator in Cancer Treatment

Introduction

Eric Stefan is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.

Latest Patents

Eric holds a patent for "Compounds and methods useful for treating or preventing cancers." This invention includes CSNK1A1 inhibitors that are beneficial in treating or preventing various types of cancer. Specifically, it addresses hematological cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), as well as colon cancer. His work in this area has the potential to impact many lives positively.

Career Highlights

Throughout his career, Eric has worked with prestigious organizations, including the Broad Institute, Inc. and Dana-Farber Cancer Institute Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Eric has had the opportunity to work alongside esteemed colleagues such as Steven M Corsello and Todd R Golub. These collaborations have further enriched his research and contributed to advancements in cancer treatment.

Conclusion

Eric Stefan's innovative work in developing cancer treatment methods showcases his dedication to improving patient outcomes. His contributions to the field are invaluable and highlight the importance of continued research in combating cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…